This report contains market size and forecasts of Molecular Diagnostic Testing Kit in global, including the following market information:
- Global Molecular Diagnostic Testing Kit Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Molecular Diagnostic Testing Kit Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Molecular Diagnostic Testing Kit companies in 2022 (%)
The global Molecular Diagnostic Testing Kit market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Bacteria Caused Disease Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnostic Testing Kit include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Diagnostic Testing Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnostic Testing Kit Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Molecular Diagnostic Testing Kit Market Segment Percentages, by Type, 2022 (%)
- Bacteria Caused Disease
- Fungi Caused Disease
- Parasites Caused Disease
- Influenza
- HIV
- Ebola
- COVID-19
- Other Virus Caused Disease
Global Molecular Diagnostic Testing Kit Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Molecular Diagnostic Testing Kit Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Scientific Research
Global Molecular Diagnostic Testing Kit Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Molecular Diagnostic Testing Kit Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Molecular Diagnostic Testing Kit revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Molecular Diagnostic Testing Kit revenues share in global market, 2022 (%)
- Key companies Molecular Diagnostic Testing Kit sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Molecular Diagnostic Testing Kit sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Cellex
- Abbott
- Roche
- BioMedomics
- BD
- Henry Schein
- Safecare Bio-Tech
- Mayo Clinic Laboratories
- Chembio Diagnostics
- Mount Sinai Laboratory
- Ortho Clinical Diagnostics
- Zhejiang Orient Gene Biotech
- Innovita Biological Technology
- Guangzhou Wondfo Biotech
- Guangdong Hecin-Scientific
- Dynamiker Biotechnology (Tianjin)
- ADVAITE
